Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.02+3.07%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ELDN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 67.9 | 66.3 | 52.0 | 30.3 | 27.1 | 23.7 | 6.1 | 8.1 | 6.8 | 2.0 | 3.2 | 32.6 | 14.6 |
| Operating Income | — | — | — | (43.0) | (88.4) | (36.9) | (18.5) | (16.1) | (14.1) | (13.1) | (5.1) | (45.3) | (23.5) |
| Earnings from Continuing Operations | |||||||||||||
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 0.2 |
| EBT, Incl. Unusual Items | — | (45.6) | (35.8) | (116.5) | (88.0) | (36.9) | (23.2) | (16.0) | (14.1) | (13.1) | — | — | — |
| Income Tax Expense | — | 0.0 | 0.4 | 0.0 | 0.0 | (2.4) | (0.4) | — | — | — | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||||||
| Net Income | (98.6) | (45.6) | (36.2) | (116.5) | (88.0) | (34.5) | (22.8) | (16.0) | (14.1) | (13.1) | (5.7) | (45.1) | (23.3) |
| Per Share | |||||||||||||
| Basic EPS | (0.87) | (0.52) | (0.75) | (4.73) | (6.16) | (2.33) | — | — | — | — | — | — | — |
| Diluted EPS | (0.87) | (0.52) | (0.75) | (4.73) | (6.16) | (2.33) | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 113.6 | 81.8 | 48.5 | 24.6 | 14.3 | 14.8 | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 113.6 | 81.8 | 48.5 | 24.6 | 14.3 | 14.8 | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||
| EBITDA | — | — | — | — | — | — | (18.5) | (16.0) | (14.0) | (13.1) | — | — | — |
| EBIT | — | — | — | (43.0) | (88.4) | (36.9) | (18.5) | (16.1) | (14.1) | (13.1) | (5.1) | (45.3) | (23.5) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 6.4% | 1.7% | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.